5- (2-furyl)-1, 3-thiazole derivatives useful as inhibitors of phosphatidylinositol 3-kinase

Details for Australian Patent Application No. 2007290359 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Cornebise, Mark; Tanner, Adam; Westcott, James; Ledford, Brian; Green, Jeremy; Parsons, Jonathan; Wang, Tiansheng

Agent Baldwins

Pub. Number AU-B-2007290359

PCT Pub. Number WO2008/027584

Priority 60/841,935 01.09.06 US

Filing date 4 September 2007

Wipo publication date 6 March 2008

Acceptance publication date 20 September 2012

International Classifications

C07D 417/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/427 - not condensed and containing further heterocyclic rings

A61P 35/00 Antineoplastic agents

A61P 37/00 Drugs for immunological or allergic disorders

Event Publications

2 April 2009 PCT application entered the National Phase

  PCT publication WO2008/027584 Priority application(s): WO2008/027584

20 September 2012 Application Accepted

  Published as AU-B-2007290359

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007290367-Phased small RNAs

2007290358-Systems, methods, software, and interfaces for formatting legal citations